Translational Study Reveals a Two-Faced Role of RBM3 in Pancreatic Cancer and Suggests Its Potential Value as a Biomarker for Improved Patient Stratification
Oncotarget - United States
doi 10.18632/oncotarget.23486
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 20, 2017
Authors
Publisher
Impact Journals, LLC